eMedevents
  • 132781+ Medical Conferences
  • 251 Specialties
  • 34891 Organizers
  • 148866 Speakers
  • 155 Countries
  • 4473 Cities
44260+
CME Conference Registrations Sold
Home  >  Speakers  >  Julia Carolin Stingl
Julia Carolin Stingl

Julia Carolin Stingl

    PhD
Vice President, Director, Professor | Bonn, North Rhine-Westphalia    Germany
Clinical Pharmacology
Clinical Pharmacology, Pharmacogenomics,...More
Spoken at 1 event
Speaking at 1 event

Biography :

Julia Carolin Stingl (formerly Kirchheiner) studied medicine at the Johann Wolfgang Goethe University in Frankfurt. In the period 1999-2004, she completed her specialist training in Clinical Pharmacology at the Charité in Berlin and in 2004 qualified as a pharmacogenetic optimization of drug therapy. In 2006, she accepted a professorship in Clinical Pharmacology at the University of Ulm. In 2012 she became Professor of Translational Pharmacology at the University of Bonn (Thuringian Model) and at the same time Head of the new Research Department at the Federal Institute for Drugs and Medical Devices. Since October 2014, Ms. Stingl has been Vice President of the Federal Institute for Drugs and Medical Devices in Bonn. For more than 15 years, she has been involved in research on pharmacogenetics and drug variability, drug safety and patient-adjusted drug dosing. It has developed pharmacogenetically based dosing adjustments for antidepressants and antipsychotics that are used in the clinical application of pharmacogenetic diagnostics and are now used in international guidelines.

Julia Stingl is associate member of the Drug Commission of the German Medical Association, member of the Pharmacogenomics Working Party of the EMA and member of the Faculty of 1000. It has developed pharmacogenetically based dosing adjustments for antidepressants and antipsychotics that are used in the clinical application of pharmacogenetic diagnostics and are now used in international guidelines.

Julia Stingl is associate member of the Drug Commission of the German Medical Association, member of the Pharmacogenomics Working Party of the EMA and member of the Faculty of 1000. It has developed pharmacogenetically based dosing adjustments for antidepressants and antipsychotics that are used in the clinical application of pharmacogenetic diagnostics and are now used in international guidelines. Julia Stingl is associate member of the Drug Commission of the German Medical Association, member of the Pharmacogenomics Working Party of the EMA and member of the Faculty of 1000.

*********************
*** *** ***
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Clinical Pharmacology

Interested Topics

Clinical Pharmacology, Pharmacogenomics, Pharmacogenetic Optimization of Drug Therapy, Pharmacogenetic Diagnostics, Translational Pharmacology, Drug Safety, Pharmacogenetics

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message